Orgenesis Inc (ORGS)
4.08
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
5.11
+1.03
(+25.25%)
After-Hours: 20:00
Orgenesis Accounts Payable (Quarterly): 13.41M for June 30, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 13.41M |
March 31, 2024 | 16.40M |
December 31, 2023 | 6.584M |
September 30, 2023 | 4.983M |
June 30, 2023 | 3.959M |
March 31, 2023 | 4.387M |
December 31, 2022 | 4.429M |
September 30, 2022 | 4.538M |
June 30, 2022 | 5.203M |
March 31, 2022 | 6.933M |
December 31, 2021 | 5.238M |
September 30, 2021 | 3.056M |
June 30, 2021 | 5.212M |
March 31, 2021 | 10.29M |
December 31, 2020 | 8.649M |
September 30, 2020 | 3.587M |
June 30, 2020 | 1.625M |
March 31, 2020 | 1.397M |
December 31, 2019 | 5.549M |
September 30, 2019 | 7.693M |
June 30, 2019 | 6.786M |
March 31, 2019 | 5.522M |
November 30, 2018 | 3.804M |
August 31, 2018 | 2.962M |
May 31, 2018 | 2.388M |
Date | Value |
---|---|
February 28, 2018 | 3.838M |
November 30, 2017 | 3.914M |
August 31, 2017 | 3.689M |
May 31, 2017 | 3.541M |
February 28, 2017 | 4.056M |
November 30, 2016 | 4.554M |
August 31, 2016 | 4.288M |
May 31, 2016 | 4.209M |
February 29, 2016 | 2.865M |
November 30, 2015 | 3.475M |
August 31, 2015 | 2.788M |
May 31, 2015 | 2.392M |
February 28, 2015 | 0.5243M |
November 30, 2014 | 1.084M |
August 31, 2014 | 0.237M |
May 31, 2014 | 0.1915M |
February 28, 2014 | 0.1708M |
November 30, 2013 | 0.1388M |
August 31, 2013 | 0.1513M |
May 31, 2013 | 0.0591M |
February 28, 2013 | 0.1348M |
November 30, 2012 | 0.1358M |
August 31, 2012 | 0.0566M |
May 31, 2012 | 0.0429M |
February 29, 2012 | 0.017M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.397M
Minimum
Mar 2020
16.40M
Maximum
Mar 2024
6.157M
Average
5.208M
Median
Accounts Payable (Quarterly) Benchmarks
Eli Lilly and Co | 2.925B |
Cormedix Inc | 3.345M |
NovaBay Pharmaceuticals Inc | 1.235M |
Palatin Technologies Inc | 3.443M |
iBio Inc | 0.358M |